Bausch Health Companies Inc. Prepaid Expense, Current
Bausch Health Companies Inc. (BHC) had Prepaid Expense, Current of $33.83 million as of 2011-03-31, per its 10-Q filed 2011-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2011-05-10
- 2011-03-31: Prepaid Expense, Current $33.83M.
- 2010-12-31: Prepaid Expense, Current $26.09M.
- 2010-09-30: Prepaid Expense, Current $41.17M.
- 2010-06-30: Prepaid Expense, Current $9.58M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2011-03-31 | $33.83M 10-Q · filed 2011-05-10 |
| 2010-12-31 | $26.09M 10-Q · filed 2011-05-10 |
| 2010-09-30 | $41.17M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $9.58M 10-Q · filed 2010-08-06 |
| 2009-12-31 | $15.38M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |